Vise Technologies Inc. Purchases Shares of 3,011 Xylem Inc. $XYL

Vise Technologies Inc. purchased a new position in shares of Xylem Inc. (NYSE:XYL) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,011 shares of the industrial products company’s stock, valued at approximately $390,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of XYL. Vanguard Group Inc. boosted its stake in Xylem by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after purchasing an additional 362,127 shares in the last quarter. Swedbank AB lifted its stake in shares of Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock valued at $480,767,000 after buying an additional 274,123 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Xylem by 689.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock valued at $443,074,000 after acquiring an additional 3,239,203 shares during the period. Finally, Northern Trust Corp raised its stake in Xylem by 2.9% in the 1st quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after acquiring an additional 94,560 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. The trade was a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the transaction, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 13,121 shares of company stock valued at $1,982,459. 0.27% of the stock is owned by company insiders.

Xylem Trading Down 3.2%

XYL stock opened at $142.58 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The company’s 50-day simple moving average is $146.17 and its 200-day simple moving average is $136.91. The firm has a market cap of $34.71 billion, a P/E ratio of 36.65, a PEG ratio of 2.50 and a beta of 1.15.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. During the same quarter in the prior year, the business posted $1.11 earnings per share. Xylem’s revenue for the quarter was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on XYL shares. Wall Street Zen raised Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Argus set a $170.00 target price on Xylem in a research report on Wednesday, October 29th. Zacks Research raised shares of Xylem from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 22nd. Mizuho set a $160.00 price objective on shares of Xylem in a report on Wednesday, October 29th. Finally, UBS Group raised their target price on shares of Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $166.90.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.